Carestream Health received FDA clearance for use of its Vue Motion image view for clinical X-ray reading on mobile devices.
The approval covers reading - not just viewing - on iPhone 4s, iPad 2, Galaxy Note and Galaxy S III mobile devices, the company announced.
“Diagnostic review of X-ray images with mobile devices can expedite patient treatment decisions and enable better collaboration, which can ultimately help enhance patient care,” Neville Skudowitz, Carestream’s global product director for healthcare information solutions, said in a statement.
Carestream recommends that during diagnostic image review, radiology professions frequently and concurrently use Vue Motion viewing tools, such as zoom, pan, and window level adjustments. This will help maximize image contrast and detail sharpness of each image displayed using Vue Motion on portable and mobile devices, according to the company.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.